MXPA05005414A - Derivados de propargil-trifluorometoxi-amino-benzotiazol. - Google Patents

Derivados de propargil-trifluorometoxi-amino-benzotiazol.

Info

Publication number
MXPA05005414A
MXPA05005414A MXPA05005414A MXPA05005414A MXPA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A
Authority
MX
Mexico
Prior art keywords
present
integer
alkyl
propargyl
trifluoromethoxy
Prior art date
Application number
MXPA05005414A
Other languages
English (en)
Spanish (es)
Inventor
David Lerner
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MXPA05005414A publication Critical patent/MXPA05005414A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA05005414A 2002-11-21 2003-11-20 Derivados de propargil-trifluorometoxi-amino-benzotiazol. MXPA05005414A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30154002A 2002-11-21 2002-11-21
PCT/US2003/037592 WO2004047756A2 (en) 2002-11-21 2003-11-20 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives

Publications (1)

Publication Number Publication Date
MXPA05005414A true MXPA05005414A (es) 2006-05-25

Family

ID=32392394

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005414A MXPA05005414A (es) 2002-11-21 2003-11-20 Derivados de propargil-trifluorometoxi-amino-benzotiazol.

Country Status (13)

Country Link
EP (1) EP1569641A2 (ja)
JP (1) JP2006507350A (ja)
KR (1) KR20050083951A (ja)
CN (1) CN1741802A (ja)
AU (1) AU2003295898A1 (ja)
BR (1) BR0315704A (ja)
CA (1) CA2507414A1 (ja)
IS (1) IS7906A (ja)
MX (1) MXPA05005414A (ja)
NO (1) NO20052979L (ja)
RU (1) RU2005119307A (ja)
WO (1) WO2004047756A2 (ja)
ZA (1) ZA200504988B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2621490A4 (en) 2010-09-29 2014-04-02 Teva Pharma PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF
CN103340859A (zh) * 2013-06-04 2013-10-09 中国科学院昆明动物研究所 侧脑室mpp+给药建立非人灵长类帕金森病动物模型的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112978A (ja) * 1982-12-21 1984-06-29 Shionogi & Co Ltd プロピニルアミノチアゾ−ル誘導体

Also Published As

Publication number Publication date
IS7906A (is) 2005-06-22
ZA200504988B (en) 2006-08-30
NO20052979D0 (no) 2005-06-17
NO20052979L (no) 2005-08-19
CN1741802A (zh) 2006-03-01
BR0315704A (pt) 2005-09-06
EP1569641A2 (en) 2005-09-07
CA2507414A1 (en) 2004-06-10
RU2005119307A (ru) 2006-01-27
WO2004047756A2 (en) 2004-06-10
AU2003295898A1 (en) 2004-06-18
KR20050083951A (ko) 2005-08-26
JP2006507350A (ja) 2006-03-02
WO2004047756A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
TWI262805B (en) Pharmaceutical composition for treating or inhibiting colonic polyps
TW369526B (en) Diazabicyclic neurokinin antagonists
TWI266761B (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
MY140525A (en) Pharmaceutical uses for alpha2delta ligands
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
MXPA03001518A (es) Composicion y metodo para inhibir la agregacion plaquetaria.
GR3034520T3 (en) 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
AU4696897A (en) Neurotrophin antagonist compositions
PL308666A1 (en) Derivatives of 11,21-bisphenyl-19-norpregnan, method of obtaining them and pharmaceutical composition containing such derivatives
CA2064853A1 (en) Indole derivatives
IL108695A (en) Pharmaceutical composition comprising polyamine derivatives and some such novel compounds
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
SG146681A1 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
MXPA05005414A (es) Derivados de propargil-trifluorometoxi-amino-benzotiazol.
TW333532B (en) Benzopyrans
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
WO2004054565A8 (en) Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders
MY144338A (en) Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
TW327598B (en) N-acetonylbenzamide fungicides
MY129094A (en) Condensed polycyclic compounds
YU89003A (sh) Prevencija zavisnosti u terapiji bola
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
NZ334317A (en) beta-lactam compounds as antibacterial agents effective against methicillin-resistant and coagulase-negative Staphylococci and process for preparing the same
ES2103675A1 (es) Nuevas piperidinas sustituidas.
AP2001002314A0 (en) Substituted benzolactam compounds.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal